4
Changes in Ownership
Cadrenal Therapeutics, Inc. Filed Acc 0001213900-23-010504
CEO and Chairman acquired 25,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Pham Quang X · CEO and Chairman
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-02-10 | Grant or award : show line 1 in the form | +25,000 | $1.94 | $48,500 | 3,300,000 | D |
Loading xslF345X03/ownership.xml…